688739 成大生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.7393.5784.8417.51513.251
总资产报酬率 ROA (%)1.6603.4064.6287.19512.508
投入资产回报率 ROIC (%)1.7363.5694.8267.49013.198

边际利润分析
销售毛利率 (%)79.63082.93883.65087.11489.851
营业利润率 (%)19.35924.20033.01546.24648.979
息税前利润/营业总收入 (%)16.65620.84528.80042.97249.201
净利润/营业总收入 (%)15.03920.45226.62339.34042.743

收益指标分析
经营活动净收益/利润总额(%)110.202119.163112.11097.58698.596
价值变动净收益/利润总额(%)8.968-4.4345.7473.2521.378
营业外收支净额/利润总额(%)-0.478-0.651-0.246-0.1540.803

偿债能力分析
流动比率 (X)20.68618.01020.31728.22826.980
速动比率 (X)19.28016.84019.13326.47125.647
资产负债率 (%)4.2394.8664.7834.0394.500
带息债务/全部投入资本 (%)-0.773-0.802-0.976-1.100-1.205
股东权益/带息债务 (%)-12,911.678-12,448.351-10,216.152-9,068.384-8,265.151
股东权益/负债合计 (%)2,258.8481,955.0381,990.5712,375.7822,122.005
利息保障倍数 (X)-6.379-6.518-6.967-13.415-282.688

营运能力分析
应收账款周转天数 (天)276.814231.847225.605205.242126.644
存货周转天数 (天)556.452555.330567.585665.725566.538